AMOEBIASIS - PowerPoint PPT Presentation

1 / 24
About This Presentation
Title:

AMOEBIASIS

Description:

AMOEBIASIS HISTORY 2yr 10mo girl Main Complaint: 7 days of loose, bloody diarrhoea and vomiting Lethargic and doesn t feed well Previous history: Uneventful ... – PowerPoint PPT presentation

Number of Views:2288
Avg rating:3.0/5.0
Slides: 25
Provided by: Bia47
Category:

less

Transcript and Presenter's Notes

Title: AMOEBIASIS


1
AMOEBIASIS
2
HISTORY
  • 2yr 10mo girl
  • Main Complaint
  • 7 days of loose, bloody diarrhoea and vomiting
  • Lethargic and doesnt feed well
  • Previous history
  • Uneventful perinatal history
  • No previous admissions to hospital
  • Numerous clinic visits in preceding months for
    diarrhoea
  • RVD status unknown
  • No TB or other infectious contacts
  • No recent travel history / No significant family
    history
  • DIET Never breastfed , Feeds on a family diet
    that includes mainly veg protein and
    carbohydrates. Denies traditional medicine
    ingestion.

3
EXAMINATION
  • Growth paramoeters
  • Weight 11kg - 73 of expected for age
  • Length 86cm Below 3rd centile
  • Head Circ 48cm On 50th centile
  • Weight for height Just below 3rd centile
  • Temp 37.1 HR135bpm RR42/m BP70mmHg syst
  • Distressed, ill-looking, pale, 7.5 dehydrated
  • Chest, CVS CNS Normal

4
EXAMINATION
  • Abdomen
  • Soft, distended abdomen with decreased bowel
    sounds
  • 3cm hepatomegaly Firm, sharp edge, smooth
    surface non-displaced and not
    tender.
  • Fullness possibly a mass lesion extending from R
    flank across midline tender to touch.
  • Normal hernial orifices and female genitalia
  • PR No exterior abnormalities noted
  • Irregular rectal mucosa
  • Bloody, foul-smelling diarrhoea mixed with pus
    noted

5
SPECIAL INVESTIGATIONS
  • FBC
  • WCC 3.12
  • Hb 9.5
  • MCV 80.1
  • Platelets 127
  • Diff Neut 42.7
  • Mono 17.8
  • Lymph 35.7
  • Eosino 1.8
  • Smear Left shift toxic granulation.
  • CRP 337
  • UE
  • 129 / 2.6 / 91 / 24 / 3.4 / 38
  • LFT
  • Tbili 13 Cbili 1
  • TP 46 Alb 17 Glob 29
  • ALP 54 GGT 32
  • ALT 68 AST81
  • Urine culture Negative
  • Stool culture Negative
  • Blood culture Negative
  • RVD Elisa Positive
  • CD4 188 (4.62)
  • TB W/Up Negative

6
SPECIAL INVESTIGATIONS
  • AXR
  • Distended loops of large bowel with air fluid
    levels
  • No free air noted
  • Abd. Sonar
  • Aperistaltic thickened loops of bowel in RFI
  • No mass seen
  • CT Abdomen
  • Fluid-filled large small bowel loops
  • Closely related bowel loops in RFI bowel wall
    thickening
  • No definite mass seen
  • Sigmoidoscopy
  • Mass seen at recto-sigmoid junction biopsy
    taken
  • Histology
  • Rectal biopsy with extensive mucosal ulceration.
  • Marked inflammatory cell infiltrate composed
    predominantly of chronic inflamm. cells and
    fibrin deposition
  • Amoebae noted and confirmed with PAS stain.

7
SUMMARY MANAGEMENT
  • 2yr 10mo girl with
  • Immunosuppression
  • Amoebic proctitis and a chronic inflammatory mass
    at the recto-sigmoid junction consistent with an
    amoeboma.
  • Treated with oral Metronidazole
  • Optimized general condition in terms of nutrition
  • Referred for initiation of HAART

8
AMOEBIASIS
9
The Organism
  • 4 species of Entamoeba
  • Nonpathogenic E. dispar, E. coli, E. hartmanni
  • Pathogenic E. histolytica
  • amoebiasis A Parasitic infection caused by the
    protozoon Entamoeba histolytica
  • 2nd to Malaria as protozoan cause of death
    worldwide
  • 10 of worlds population infected Increased
    prevalence in developing countries (up to 25)
  • In SA More common in KZN
  • Factors contributing to faecal-oral spread
  • Poor education
  • Poverty and overcrowding
  • Unsanitary conditions
  • HIV infection

10
The Life Cycle
  • 1. Cyst Stage
  • Infective stage
  • Survive from 4 to 40 Celcius
  • Size 12mm
  • Quadrinucleated
  • Ingested by contact with fecally contaminated
    food
  • Passes through stomach, excysts in lower small
    bowel.
  • Metacystic amoeba with four cystic nuclei from
    each cyst
  • 8 Small trophozoites from each metacystic amoeba
  • Trophozoites carried to cecum

11
The Life Cycle
  • The Trophozoite Stage
  • 10-40 qm, fragile
  • Uninucleate
  • Erythrophagocytosis
  • Reside, feed and multiply by binary fission in
    lumen of colon
  • May invade Lytic physical mechanisms and
    metastasize to liver and other extra-intestinal
    sites
  • Galactose-containing molecules receptors
    regulate cyst formation
  • Precyst Cyst Uninucleate to Quadrinucleate
    and passed in stool

12
(No Transcript)
13
The Pathogenesis
  • 10 of infected individuals develop invasive
    disease
  • Factors contributing to developing invasive
    disease
  • Pathogenicity of infecting Entamoeba species
  • Dose of inoculum
  • Host factors Impaired cell-mediated immunity, on
    steroids
  • Virulence of infecting species
  • Presence of surface adhesion factors
  • Release of proteolytic enzymes
  • Release of cytotoxins and inflicting of cytolysis

14
The Pathogenesis
  • Trophozoites adhere to colonic mucosal
    glycoproteins via a galactose and
    N-acetyl-D-galactosamine-specific lectin.
  • (Gal/GalNac) Lectin is 260kD-surface protein
    consisting of a 225kD subunit and a 35kD subunit.
  • Adherence results in cell lysis (apoptosis) and
    PMN invasion
  • PMNs are then lysed releasing lytic enzymes,
    causing more tissue destruction
  • Small foci of necrosis in the intestinal wall
    coalesce to form ulcers (Flask-shaped ulcers)
  • Parasites resist destruction by complement arm of
    immune system via Gal/GalNac mediated
    inhibition of the membrane attack complex
  • Cell-mediated immunity is important in clearing
    infection through generating ?-INF and TNF-a to
    activate macrophages and neutrophils to kill the
    trophozoite

15
The Pathogenesis
  • Area most commonly involved Cecum, then
    Recto-sigmoid area
  • May invade blood vessels causing thrombosis,
    infarction and dissemination via portal
    circulation to liver and extra-intestinal sites
    eg. brain, pleura, pericardium and genito-urinary
    system.
  • Flask-shaped ulcers

16
The Clinical Features
  • Many infections Asymptomatic cyst passers
  • Symptomatic infections may have a gradual, acute
    or rapid, fulminant course.
  • Clinical incubation period 4 days to several
    months
  • Often gradual development of symptoms Irregular
    bouts of diarrhoea, abdominal pain, weight loss,
    nausea, loss of appetite
  • (amoebic proctocolitis)
  • Less often sudden onset of copious diarrhoea
    containing mucus and blood.
  • Findings may include low-grade fever, tenderness
    on palpation of the abdominal wall overlying
    involved large bowel.

17
The Complications
  • Complications of Intestinal amoebiasis
  • Fulminant Amoebic Colitis with Perforation
  • May have a mortality rate of up to 50
  • Children less than 2 yrs at increased risk of
    perforation
  • Massive Haemorrhage
  • Due to vasculitis of large arteries or multiple
    ulcers leading to small arterial leaks
  • amoebomas
  • A granulomatous thickening of the colon resulting
    from lytic necrosis followed by secondary
    pyogenic inflammation, leading to fibrosis and
    proliferative granulation tissue. Lesions are
    firm, hard, may resemble a carcinoma.
  • amoebic Stricture
  • Resulting from fibrosis of intestinal wall. Can
    involve rectum, anus or sigmoid.

18
The Complications
  • Complications of Extra-Intestinal Amoebiasis
  • Amoebic Liver Abcess
  • Most frequent complication of amoebiasis
  • MaleFemale Ratio 1 in Children and infants
  • In adulthood More common in young males
  • Third to Half may have no history of diarrhoea
  • Commonly found in Right Lobe of liver
  • Presents acutely with high fever, RUQ tenderness
  • Jaundice an unusual finding
  • Have marked leucocytosis and may have XR
    abnormalities in 25 to 90 of patients

19
The Complications
  • Complications of Extra-Intestinal amoebiasis
  • amoebic Peritonitis
  • As a complication of a ruptured hepatic abcess
  • Pleuropulmonary amoebiasis
  • Caused by rupture of Rt. Lobe Liver abcess in 10
    of patients
  • Has cough, pleuritic chest pain dyspnoea
  • amoebic Pericarditis
  • Rare, but most serious complication in 3 of pts.
    with liver involvement
  • Rupture of Left Lobe liver abcess
  • Cerebral amoebiasis
  • Rare, has altered consciousness and focal neuro
    signs
  • CT Irregular lesions without surrounding
    capsule or enhancement
  • Genito-Urinary Involvement
  • Painful genital ulcers Punched out appearance
    profuse discharge

20
The Diagnosis
  • Light Microscopy of Stool
  • Identification of trophozoites / cysts in fresh
    stool
  • Disadvantages
  • Not sensitive (miss up to two thirds of
    infections)
  • Cannot distinguish between E.histolytica and E.
    dispar
  • Serology
  • Anti-amoebic antibodies (IgM) 70 sensitive for
    amoebic colitis and 90 sensitive for amoebic
    liver abcess
  • Stool antigen-detection test or PCR
  • Sensitive and Specific
  • Disadvantages
  • Antigen detection test (EIA) only available from
    Blacksburg VA

21
The Diagnosis
  • Colonoscopy / Sigmoidoscopy
  • Colonoscopy preferable
  • Wet preps of material from ulcer-base can show
    trophozoites
  • Biopsies should be taken from edge of ulcers
  • Recommended to evaluate for amoebic colitis even
    when Ulcerative Colitis considered

22
The Diagnosis
  • amoebic Liver Abcess
  • Diagnosis relies on
  • Detection of risk factors for E.histolytica
    infection
  • Positive Serology
  • Lesion in Liver
  • Abdominal USS
  • Abdominal CT Well-rounded, wall enhances
  • Aspiration may yield anchovy-paste material
  • More often yellow / gray-green
  • Often odourless and sterile Highly suggestive
    of amoebic abcess

23
The Management
  • Asymptomatic infections
  • Luminal agent only recommended but ?not available
    in SA
  • In general, not treated in endemic areas
  • Symptomatic infections
  • Oral Metronidazole for 10 days
  • Effective in eradicating amoebae in bowel lumen
    and wall
  • Effective in eradicating extra-intestinal disease
  • Additional luminal agent not necessary
  • E. dispar infection doesnt require treatment

24
Prevention
  • Improved sanitation and clean water supply reduce
    fecal-oral transmission
  • Boiling water, Washing veg with vinegar
  • Vaccination
  • None available currently
  • Prototype subunit vaccines based on the
    Gal/GalNAc-lectin under study
Write a Comment
User Comments (0)
About PowerShow.com